Argenx
ARGX
#549
Rank
C$50.90 B
Marketcap
$833.69
Share price
0.99%
Change (1 day)
62.23%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): C$0.12 Billion

According to Argenx 's latest financial reports the company's current earnings are C$2.19 Billion. , an increase over its 2023 earnings that were of -C$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 C$0.11 B-127.97%
2023 -C$0.43 Billion-58.25%
2022 -C$1.02 Billion
2019 -C$0.28 Billion124.95%
2018 -C$0.13 Billion132.04%
2017 -C$52.95 Million54.86%
2016 -C$34.2 Million33%
2015 -C$25.71 Million13.63%
2014 -C$22.63 Million46.25%
2013 -C$15.47 Million